Looijenga L H, Gillis A J, van Gurp R J, Verkerk A J, Oosterhuis J W
Laboratory for Experimental Patho-Oncology, Dr. Daniel den Hoed Cancer Center, Academic Hospital Rotterdam, The Netherlands.
Am J Pathol. 1997 Aug;151(2):581-90.
In female mammalian cells, inactivation of one of the X chromosomes compensates the increased dosage of X-linked genes as compared with their male counterparts. This process is initiated by the X-inactive specific transcripts of the xist/XIST gene in cis, resulting in methylation of specific sites of genes to be silenced. However, in male germ cells, X inactivation is established by xist/XIST expression only. We investigated the X inactivation pattern in human testicular tumors of different histogenesis by analysis of XIST expression and methylation of the androgen receptor gene. XIST was expressed only in tumors derived from the germ cell lineage with supernumerical X chromosomes: seminomas, nonseminomas, and spermatocytic seminomas. Although low expression was present in testicular parenchyma with spermatogenesis, XIST was expressed at a higher level in parenchyma with carcinoma in situ, the precursor lesion of seminomas and nonseminomas. Despite the consistent expression of XIST in germ-cell-derived tumors with gain of X chromosomes, methylation of the androgen receptor gene was present in all differentiated but only in a proportion of the undifferentiated nonseminomas. This differential pattern of methylation was also found in a number of representative cell lines. Our data indicate that the counting mechanism resulting in X inactivation is functional in testicular cancers of different histogenesis. Moreover, the differentiation-dependent pattern of X inactivation as reported during normal development in the case of multiple X chromosomes by methylation is retained in these tumors. We conclude therefore that X inactivation allows the excessive gain of X chromosomes found in germ-cell-derived tumors of the adult testis. In addition, this offers an interesting model to study the fundamental mechanisms of these processes.
在雌性哺乳动物细胞中,一条X染色体的失活补偿了与雄性对应细胞相比X连锁基因增加的剂量。这个过程由顺式作用的xist/XIST基因的X失活特异性转录本启动,导致待沉默基因特定位点的甲基化。然而,在雄性生殖细胞中,X染色体失活仅通过xist/XIST的表达来建立。我们通过分析XIST的表达和雄激素受体基因的甲基化,研究了不同组织发生类型的人类睾丸肿瘤中的X染色体失活模式。XIST仅在源自具有额外X染色体的生殖细胞谱系的肿瘤中表达:精原细胞瘤、非精原细胞瘤和精母细胞性精原细胞瘤。尽管在有精子发生的睾丸实质中存在低水平表达,但XIST在原位癌(精原细胞瘤和非精原细胞瘤的前体病变)的实质中表达水平更高。尽管在具有X染色体增加的生殖细胞源性肿瘤中XIST持续表达,但雄激素受体基因的甲基化存在于所有分化的非精原细胞瘤中,而仅在一部分未分化的非精原细胞瘤中存在。在一些代表性细胞系中也发现了这种甲基化的差异模式。我们的数据表明,导致X染色体失活的计数机制在不同组织发生类型的睾丸癌中起作用。此外,在正常发育过程中多个X染色体情况下通过甲基化报道的X染色体失活的分化依赖性模式在这些肿瘤中得以保留。因此,我们得出结论,X染色体失活允许在成人睾丸的生殖细胞源性肿瘤中发现的X染色体过度增加。此外,这为研究这些过程的基本机制提供了一个有趣的模型。